MB-dNPM1-TCR.1 in Relapsed/Refractory AML

Clinical trial NCT06424340 · RECRUITING

Trial details

NCT number: NCT06424340
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2024-08-01
Primary completion: 2028-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.